亞太地區高度活躍的 API 市場 - 分析與預測（2023-2033）

亞太地區高度活躍的 API 市場規模預計將從 2023 年的 74.9 億美元增至 2033 年的 256.8 億美元，2023-2033 年的複合年成長率為 13.11%。

癌症盛行率的增加正在推動對高活性 API 的需求，而這些高活性 API 在各種醫療疾病中的治療應用的擴大是推動亞太地區高活性 API 市場成長的關鍵因素。

由於慢性病的流行和對標靶治療的需求不斷成長，亞太地區高活性藥物成分（HPAPI）市場正在迅速擴大。 HPAPI 在創造高效藥物方面發揮著重要作用，特別是在治療荷爾蒙失衡、癌症和某些其他醫療狀況方面。由於該地區製藥業的發展以及製造能力和技術的提高，市場正在不斷擴大。

這種擴張是由受益於強大的基礎設施、技術純熟勞工和促進成長的法律體制的國家主導的。此外，受託製造廠商（CMO）的成長和研發投資的增加進一步增加了市場潛力。

本報告研究了亞太地區高活躍 API 市場，提供了特定國家的趨勢和進入市場的公司概況。

目錄

執行摘要

第1章 市場

• 趨勢：當前和未來的影響評估
• 供應鏈/價值概述
• 價格分析
• 專利申請趨勢（按年份、按國家）
• 監管狀況
• 全球重大事件的影響分析 - COVID-19
• 市場動態：概述

第2章 區域

• 區域概況
• 亞太地區

第3章市場－競爭基準化分析與公司概況

• 未來展望
• 地理評估
  • Asymchem Inc.
  • Dr. Reddy's Laboratories Ltd.
  • CARBOGEN AMCIS

第4章調查方法

Introduction to Asia-Pacific (APAC) Highly Potent API Market

The Asia-Pacific highly potent API market is projected to reach $25.68 billion by 2033 from $7.49 billion in 2023, growing at a CAGR of 13.11% during the forecast period 2023-2033. The increasing prevalence of cancer is driving the demand for highly potent APIs, and the expanding therapeutic applications of these potent APIs across a range of medical disorders are the main factors driving the growth of the APAC extremely potent API market.

Market Introduction

The market for highly potent active pharmaceutical ingredients (HPAPI) in Asia-Pacific is expanding quickly due to the growing prevalence of chronic illnesses and the growing need for targeted therapeutics. HPAPIs play a crucial role in the creation of extremely potent drugs, especially in the treatment of hormone imbalances, cancer, and other specific medical conditions. The market is growing thanks to the region's developing pharmaceutical industry, as well as improvements in manufacturing capacity and technology.

Leading the way in this expansion are nations which gain from strong infrastructure, highly skilled workers, and legislative frameworks that encourage growth. Additionally, the market's potential is being further enhanced by the growth of contract manufacturing organizations (CMOs) and greater investment in research and development. This research explores the APAC HPAPI market's future trends, key players, regulatory landscape, and current market dynamics, offering insightful information to stakeholders hoping to take advantage of new business possibilities in this rapidly expanding industry.

Market Segmentation

Segmentation 1: by Region

• China
• Japan
• India
• South Korea
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Competitive Strategy: The Asia-Pacific highly potent API market has numerous established players with product and service portfolios. Key players in the Asia-Pacific highly potent API market analysed and profiled in the study involve established players offering product and services of highly potent API.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, type portfolio, and market penetration.

Some prominent names in the market include:

• Asymchem Inc.
• Dr. Reddy's Laboratories Ltd.
• CARBOGEN AMCIS

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Trend 1: Advancements in Containment Technologies for Highly Potent APIs
  • 1.1.2 Trend 2: Increasing Investment for Highly Potent API Manufacturing Units
  • 1.1.3 Trend 3: Pharmaceutical Companies Outsourcing Highly Potent APIs Production to CDMOs
• 1.2 Supply Chain /Value Overview
  • 1.2.1 Supply Chain and Risks within the Supply Chain
  • 1.2.2 Value Chain Analysis
• 1.3 Pricing Analysis
• 1.4 Patent Filing Trend (by Year, Country)
• 1.5 Regulatory Landscape
• 1.6 Impact Analysis for Key Global Events - COVID-19
• 1.7 Market Dynamics: Overview
  • 1.7.1 Market Drivers
    • 1.7.1.1 Increasing Incidence of Cancer Leading to Demand in the Adoption of Highly Potent APIs
    • 1.7.1.2 Advancements in Drug Delivery Technologies
    • 1.7.1.3 Expanding Therapeutic Applications of Highly Potent API
  • 1.7.2 Market Opportunities
    • 1.7.2.1 Growing Emphasis on Personalized Medicine
    • 1.7.2.2 Increasing Opportunities for Pharma Companies in Developing Markets
  • 1.7.3 Market Restraints
    • 1.7.3.1 Regulatory Complexity for Highly Potent APIs' Manufacturing
    • 1.7.3.2 High Development and Production Costs

2 Regions

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 China
  • 2.2.5 India
  • 2.2.6 Japan
  • 2.2.7 Australia
  • 2.2.8 South Korea
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets -Competitive Benchmarking & Company Profiles

• 3.1 Next Frontiers
• 3.2 Geographic Assessment
  • 3.2.1 Asymchem Inc.
    • 3.2.1.1 Overview
    • 3.2.1.2 Key Developments
    • 3.2.1.3 Top Products/Product/Service Portfolio
    • 3.2.1.4 Top Competitors
    • 3.2.1.5 Key Personnel
    • 3.2.1.6 Analyst View
  • 3.2.2 Dr. Reddy's Laboratories Ltd.
    • 3.2.2.1 Overview
    • 3.2.2.2 Key Developments
    • 3.2.2.3 Top Products/Product/Service Portfolio
    • 3.2.2.4 Top Competitors
    • 3.2.2.5 Key Personnel
    • 3.2.2.6 Analyst View
  • 3.2.3 CARBOGEN AMCIS
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products/Product/Service Portfolio
    • 3.2.3.3 Key Developments
    • 3.2.3.4 Top Competitors
    • 3.2.3.5 Key Personnel
    • 3.2.3.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Highly Potent API Market, Recent Developments
• Figure 2: Highly Potent API Market: Value Chain Analysis
• Figure 3: Highly Potent API Market: Pricing Analysis
• Figure 4: Highly Potent API Market, Patent Analysis (by Year), January 2018-December 2023
• Figure 5: Highly Potent API Market, Patent Analysis (by Country), January 2018-December 2023
• Figure 6: Regulatory Framework for Highly Potent API
• Figure 7: Impact Analysis of Market Navigating Factors, 2022-2033
• Figure 8: Incidence of Cancer (by Region), Million, 2020-2040
• Figure 9: Asia-Pacific Highly Potent API Market, $Billion, 2022-2033
• Figure 10: China Highly Potent API Market, $Billion, 2022-2033
• Figure 11: India Highly Potent API Market, $Billion, 2022-2033
• Figure 12: Japan Highly Potent API Market, $Billion, 2022-2033
• Figure 13: Australia Highly Potent API Market, $Billion, 2022-2033
• Figure 14: South Korea Highly Potent API Market, $Billion, 2022-2033
• Figure 15: Rest-of-Asia-Pacific Highly Potent API Market, $Billion, 2022-2033
• Figure 16: Some of the Key Innovators in the Highly Potent API Landscape
• Figure 17: Highly Potent API Market: Geographical Assessment
• Figure 18: Strategic Initiatives, January 2021-December 2023
• Figure 19: Share of Strategic Initiatives
• Figure 20: Data Triangulation
• Figure 21: Top-Down and Bottom-Up Approach
• Figure 22: Assumptions and Limitations

List of Tables

• Table 1: Asia-Pacific Highly Potent API Market Snapshot
• Table 2: Short-Term and Long-Term Opportunities and Risks (by Region)
• Table 3: Key Trends, Impact Analysis
• Table 4: Highly Potent API Market, Key Investment
• Table 5: Recent Innovations for Manufacturing and Handling of Highly Potent Drugs
• Table 6: Highly Potent API Market (by Region), $Billion, 2022-2033
• Table 7: Highly Potent API Market (by Country), $Billion, 2022-2033